Description
Diffuse parenchymal illnesses, often known as interstitial lung disease (ILD), are a group of diverse lung conditions categorized according to common clinical, radiological, physiological, or pathologic features. The complicated nomenclature used to describe this category of disorders makes understanding them challenging. As the name suggests, the pathogenetic sequence actually entails a series of inflammation and fibrosis that also involves altering the parenchyma, which includes the alveoli, alveolar ducts, and bronchioles. The number of factors that might lead to infiltrative illnesses is endless. Many are really uncommon. Different groups spread diseases in different ways, therefore it's important to get the right diagnosis.
Résumé
- Interstitial lung diseases (ILDs) are a heterogeneous group of over 100 distinct lung disorders sharing clinical, radiographic, or pathological features. ILD is an umbrella term encompassing a variety of conditions affecting the lungs.
- The primary issue in ILDs is damage to the area where gas exchange occurs between the alveoli and blood vessels. This damage impairs air exchange, resulting in oxygen deficiency and hypoxia in the patient.
- Pathophysiologically, ILDs involve increased fibroblastic proliferation, leading to fibrosis and increased collagen deposition around the gas exchange area. Historically, ILDs were referred to as diffused parenchymal diseases.
- Classifying ILDs is challenging, and various classifications have been proposed. The complexity stems from the diverse nature of the diseases and the varying degrees of inflammation and fibrosis observed.
Exemple de certificat
À propos des intervenants
Dr Deepanjali Sharma
Pneumologue consultant à l'hôpital Shree Ram Care, Bilaspur, Chhattisgarh.
Divulgation financière
Commentaires
Commentaires
Vous devez être connecté pour laisser un commentaire.